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The Ia antigens in mice and the HLA-DR antigens  in man play a  critical  role in 
the interaction  of T  lymphocytes and macrophages in antigen  recognition  (1,  2).  In 
contrast to the murine I region, resolution of the complexity of the human HLA-D/ 
DR region has been difficult  because of limited  information  from genetic  recombi- 
nation.  Furthermore,  the  exact  nature  of  the  determinants  involved  in  cellular 
interactions  is uncertain  because they can be defined only with polyclonal antisera. 
Clarification of the role of DR antigens in various functions controlled by this region 
would be facilitated  by monoclonal antibodies  directed  against  polymorphic deter- 
minants.  Whereas many monoclonal antibodies  precipitating  DR-like antigens have 
been described, the relationship between these molecules and DR antigens defined by 
alloantisera  remains  unclear,  riaainly  because  thesd  xenogeneic  antibodies  detect 
monomorphic  (3-6),  supertypic  (4,  6),  or other  determinants  on DR-like molecules 
(7).  To date,  no monoclonal antibody directed  against  an epitope  with  the  genetic 
and biochemical characteristics  of a  single DR alloantigen  has been reported  (8,  9). 
In this  report,  we characterized  a  mouse  monoclonal  antibody  (16.23)  detecting  a 
DR-type molecule that is correlated with the HLA-DR3 alloantigen. 
Materials  and Methods 
Reagents.  The origin and maintenance of the cell lines have been described (10). The Rewi 
cell line was produced by Epstein-Barr virus transformation of peripheral blood lymphocytes 
(PBL) 1 from a homozygous HLA-Dwl, DR1 donor. The cytotoxic monoclonal antibody 16.23 
(IgG3)  was obtained  from a  BALB/c mouse immunized  with  a  single  injection  of human 
melanoma cell line Mel JuSo. When tested in a binding assay with a panel of 27 cell lines,  it 
bound only to the immunizing tumor and to an autologous B cell line (10). The JuSo B cell 
line and PBL were typed as HLA A1, 2; B7, 8; Cw-; DR2, 3. The specificities  and numbers of 
individual HLA-D homozygous typing cells  (HTC) used were: HLA-Dwl (5), Dw2 (7), Dw3 
(5), Dw4 (2), Dw5 (1), Dw6 (3), Dw7 (1), Dw8 (~), Dw9 (2), and undefined (1). The HLA-A, 
* Supported by the Deutsche Forschungsgemeinschaft, Bonn, through the Sonderforschungsbereich 37 
(B9). 
a Abbreviations used in this paper."  BSA,  bovine serum albumin; FCS, fetal calf serum; FITC, fluorescein 
isothiocyanate; HTC,  homozygous typing  cells; Mr,  relative molecular mass; PBL, peripheral  blood 
lymphocytes, PBS, phosphate-buffered saline; PMSF, phenyl methyl sulfonyl fluoride; SDS-PAGE, sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis; SpA, protein A. 
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B, C, D, and DR antigens of the JuSo cells, families,  unrelated panel, and HTC were defined 
with local reagents or those of the VII and VIII International Histocompatibility Workshops. 
Dr. G. B. Ferrara  (Hopital St.  Louis, Paris, France), Dr. V. Lepage (Ruhr University, Essen, 
Federal  Republic  of Germany),  and  Dr.  H.  Grosse-Wilde  (Immunohematology Research 
Center,  Massa,  Italy)  kindly  provided  many of the  HLA alloantisera.  A  rabbit  antiserum 
against HLA-DR fl chains was the kind gift ofJ. F. Kaufman, Basel Institute of Immunology, 
Switzerland. 
Typing of PBL for Reactivity with Antibody 16.23.  PBL were tested with  16.23 by microcyto- 
toxicity,  indirect  immunofluorescence,  or autoradiography.  B-  and  T-enriched  lymphocyte 
fractions were obtained using polymethylaerylate bead columns (11) (Degalon Perlen, Degussa, 
Frankfurt, Federal Republic of Germany) and characterized by E-rosetting and direct immu- 
nofluorescence  (fluorescein  isothiocyanate [FITC]-goat anti-human  IgG, Medac,  Frankfurt, 
FRG).  Immunofluoreseence with  16.23 was performed on  72-h  phytohemagglutinin  (PHA) 
blasts (1% PHA-m, Difco Laboratories, Detroit, MI) using culture supernatant and FITC-goat 
anti-mouse Ig (Medac).  16.23 was purified from culture fluid by affinity chromatography on 
protein A (SPA)  Sepharose CL (Pharmacia, Upsalla, Sweden) eluted with 0.1 M  glycine, pH 
3,  and  iodinated  with  ehloramine  T  (12) for use in autoradiography. An IgG3 monoclonal 
antibody  (15.95)  reacting with  melanoma and  carcinoma cell  lines  (10) and  anti-HLA-DR 
monomorphic monoclonal antibodies (3) were used as controls. 
Isolation of Antigen Subunits and Direct Binding of Antibody 16.23.  Cell surface iodination, lysate 
preparation,  immunoprecipitation, sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE), and autoradiography were performed as described (10). Iodinated HLA-DR-Iike 
antigens were eluted from 16.23-SPA Sepharose (10) with 8 M urea (RT, 1 h), and the subunits 
were separated by SDS-PAGE (10%) under nonreducing conditions. The unfixed gel was dried 
and exposed for 4-6 h. Three bands of radioactivity were obtained, two of which (Mr 35,000 
and 25,000)  were shown by subsequent SDS-PAGE to correspond to the a  (Mr 37,000)  and fl 
(Mr 31,000) subunits. The 35 and 25 kd bands were eluted from the gel in 0.01 M Tris-HCl, pH 
8, containing 0.1%  Nonidet  P-40,  1 mM  benzamidine  HCI,  I  mM phenyl methyl sulfonyl 
fluoride (PMSF), and 1% bovine serum albumin (BSA) (7 h at 4°C). 70-89% of the radioactivity 
was  recovered.  To  assess antibody  binding,  subunits  in  50%  fetal  calf serum  (FCS)  were 
incubated with myeloma supernatant  MPC  11-SpA Sepharose  (1  h, 4°C,  10/tl  packed gel) 
followed by 16.23-SPA  Sepharose  (2 h, 4°C,  10/tl packed gel). The bound radioactivity was 
measured and analyzed on a  10% SDS-PAGE under reducing conditions. The material in each 
lane was estimated by scanning the autoradiographs at 405 nm (ISCO gel scanner, model 1310, 
type 6 optical unit; ISCO, Instrumentation Specialties Co., Lincoln, NE). 
Western Blotting and Detection of Antigen in Cell Lysates.  Cell lysates (5 ×  104 to 5 ×  l0  s cells) 
containing 8 M  urea or 1% SDS were heated for 30 min at 45°C or for 2 min at  100°C and 
electrophoresed under nonreducing conditions in  10% SDS-PAGE with or without 6 M  urea. 
The  separated  proteins  were  electrophoretically  transferred  (13) to  a  nitrocellulose  filter 
(Schleicher and  Schiill,  BA 0.45~,  Dassel,  Federal  Republic of Germany)  for  1.5 h  at  30 V 
using two carbon plates as electrodes and foam rubber pads soaked in transfer buffer (0.025 M 
Tris, 0.192 M glycine, pH 8.3, plus 20% methanol). The filter was incubated overnight in 0.1% 
gelatin  in  phosphate-buffered  saline  (pH  7.2) containing 0.1%  NaN3 and  0.05%  Tween-20 
(Fluka AG, Buchs, Switzerland)  (PBS-Tween).  The blocked filter was incubated  for  1 h  in 
16.23 culture supernatant  (plus 0.05% Tween-20), washed in PBS-Tween, incubated  1 h with 
[I125]SpA in 10% FCS (10  s cpm/ml; iodinated with chloramine T) (12), washed (PBS-Tween), 
and autoradiographs prepared. 
Results 
Antibody  16.23  Is  Directed against  an  HLA-linked  Antigen  Closely Associated  with 
HLA-D/DR3.  Fresh  PBL  from  the  melanoma  patient  JuSo  was  analyzed  using 
immunofluorescence and autoradiography for the presence of cells binding 16.23. The 
reactivity observed was restricted  to the B  cell-enriched  fraction  (15-28% of the Ig  ÷ 
cells),  and  these cells  were shown  by double  marker  studies  to be non-E-rosetting, 
surface Ig-positive cells. 106  MONOCLONAL  ANTIBODY AGAINST HLA-DR3 
In  an analysis of PBL  from  seven  unrelated  individuals selected  from  an  HLA- 
typed  panel,  only  two  reacted  with  16.23,  suggesting  that  the  antigen detected  is 
polymorphic in the population. Subsequent analysis of four families established that 
the antigen defined by 16.23 segregates in tight linkage with HLA  (Table I). 
Because the tissue distribution suggested  that  antibody  16.23  might  detect  a  DR 
antigen, 32 unrelated HLA-DR  typed individuals (specifieities 1-8) and 28 HTC  (Dw 
specificities  1-9)  were  analyzed. A  strong association between reactivity with  16.23 
and the HLA,Dw/DR3  phenotype was found (Table II). Antibody 16.23 was positive 
with cells of the eight DR3  heterozygotes  and the five homozygous Dw3 individuals 
examined. It also reacted with two of three Dw6 homozygous cells and with cells of 
three of five DRw6 heterozygotes. Reactivity with other specificities was not observed. 
Biochemical  Characterization  of the 16.23 Antigen.  The iodinated surface polypeptides 
precipitated by antibody  16.23  from Mel JuSo, the autologous B  cell (JuSo  B), and 
the allogeneic B  cell Raji (HLA-DR3, w6)  are compared  in Fig.  1. Two components 
of Mr 37,000  (a chain)  and 31,000  (fl chain) were obtained from all three cell lines. 
(Under nonreducing conditions, these subunits migrated  with  apparent  35,000  and 
25,000  mol wt,  respectively;  Fig.  3).  The 44,000  mol wt  component observed  in the 
JuSo B  precipitate (lane c) might be actin, which frequently contaminates B  lympho- 
TAaI.E  I 
Segregation of 16.23 Epitope with HLA 
Family  Father  Mother 
Children 




a  A3,BI8,Cw5,Dw3/DR3* I 
b  A2,B  13,Cw6,--/-- 
a  A2,B27,Cw  I,Dw2/DR2  Ja 
b  A2,B13,--,--/--  a/d 
a  A2,Bw35,Cw4,--/DR5 
b  --, B7,w6,--,--/DR2 
a  A2,B  12,--,--/DR4 
b  A  11,Bw35,--,--/DR4 
d  A2, B5, --,DwS/DR5  b/d  b/c  b/c 
d  A3, B7,--,Dw2/DR2  a/d  a/d  b/d  a/d 
r"--"q 
c  A  I,B8,--,--/DR  l,Glo2  [ Sa  [  Lo 
d  AI,B8,~',7-/DR3,GIol ]  I a/d[  a/c 
i 
Co  Ei  Ca  Da  Dv 
l.d  A2,Bwl8,--,Dw3/DR3 [  ale  a/c  b/c  b/c  b/c 
*  Boxes indicate  reactivity  with 16.23. 
Linkage  was determined  using  the method  of lod scores (0~. = 0.0, lod score = 3.607;  odds, 4,000:1;  zLa-  = 1.506  zLe = 1.80,  and zw6 = 0.301) (14). 
TABLE II 
Correlation between 16.23 Epitope and HLA-Dw/ DR3 
Cells  ++*  +-  -+  --  N:t:  X  2  P value 
Heterozygotes  8  3  0  21  32  16.67  P < 0.005 
Homozygotes  5  2  0  21  28  13.72  P < 0.005 
* 16.23 positive,  Dw/DR3 positive.  All individuals in category  +-  were  typed as 
HLA-Dw/DRw6. 
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FtG.  1.  Immunoprecipitates  with  antibody  16.23. Cells were labeled by surface iodination  and 
immunoprecipitated  with MPC 11 or 16.23, and the antigens were analyzed by 10% SDS-PAGE as 
described (10). Antibody  16.23 immunoprecipitates  from Mel JuSo (a), Raji (b), and JuSo B ceils 
(c). MPC  11 immunoprecipitates  from Mel JuSo (e) and JuSo B cells (f). Lane d gives molecular 
weight  markers:  bovine  serum  albumin  (69,000), ovalbumin  (46,000), and  carbonic  anhydrase 
(30,000). The numbers on the ordinate indicate the migration oftbe marker proteins with molecular 
weight in kilodaltons. 
cyte  immunoprecipitates  (5);  it  was  not  observed  in  nonreducing  conditions  nor  in 
preclearing precipitates  (lanes e and f). In addition to these DR-like a  and fl subunits, 
16.23  consistently  precipitated  a  smaller  28,000-mol  wt  component  from  Mel JuSo 
cells  (lane a). 
Subunit  Localization  of the HLA-DR3-associated Determinant.  To  localize  the  epitope 
defined  by this  antibody,  iodinated  antigen  was isolated  from JuSo  B  cells,  and  the 
subunits  were separated  and tested  directly for reactivity with  16.23.  Antibody  16.23 
and  control  Ig  MPC  11  bound  equivalent  amounts  of the  a  subunit  (Fig.  2).  In 
contrast,  16.23  bound  >50%  of the fl chain  radioactivity,  whereas  MPC11  binding 
remained at background levels. This bound material was eluted and analyzed in SDS- 
PAGE  (Fig.  2). Labeled polypeptides were observed only in the  16.23-fl chain eluate, 
and this material migrated in the position of the smaller molecular weight fl subunit. 
In  a  second  approach,  the  electrophoretically  separated  unlabeled  cell  lysate 
proteins from JuSo (DR2, 3) and Rewi (DR 1) were transferred to nitrocellulose filters. 
These  filters were  then  incubated  with  16.23,  MPC  11,  or rabbit  antiserum  against 
DR fl chains,  followed by [I125]SPA.  Location  of the a-fl complex and  the separated 
a  and fl subunits was determined by running immunoprecipitated  125I-labeled antigen 
on  the same gel.  In lysates containing  1% SDS  and  heated  to 45°(2,  the  majority of 
the  16.23-binding  activity was found in a  position corresponding  to the undissociated 
t~-fl complex, although substantial binding was also observed to a band in the position 
of the fl chain  (Fig.  3, lane c). When  these  lysates were heated  to  100°C  (separating 
the  a  and  fl  chains  completely,  lane  b),  binding  of  16.23  was  still  obtained  but 
restricted  to the lower molecular weight  band  (lane d).  The rabbit  antiserum  bound 
to a  band in a  similar position  in both JuSo and Rewi cells  (lanes e  and g), although 108  MONOCLONAL  ANTIBODY  AGAINST  HLA-DR3 
.  p 
16.23÷  ~:  50A  Y, 
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c 
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mpc11+K:  2.9  ~  "  " 
e 
--  + 
FIG.  2.  Direct binding of 16.23 to isolated subunits of DR-like antigen. Iodinated DR-like subunits 
precipitated  by  16.23 from JuSo B  cells were isolated  and incubated with  16.23 or MPC  11,  as 
described  in  Materials  and  Methods.  The  eluted  material  was  separated  on  SDS-PAGE  (10%, 
reduced  samples),  and the autoradiographs  were analyzed  by densitometry.  The optical  density 
(405 nm, OD~  =  1) is presented on the ordinate, and the abscissa indicates the migration distance 
from the top (-) of the gel. The percent of radioactivity bound by the antibody is indicated for each 
sample:  a, a,  and fl subunits precipitated  by  16.23  from JuSo  B  cells;  b,  material  eluted  from 
16.23-fl subunit precipitate (input 1158 cpm); c, material eluted from MPC 11-fl suhunit precipitate 
(input 2048 cpm); d, material eluted from 16.23-0t subunit precipitate (input 1120 cpm); e, material 
eluted from MPC-11-a subunit preciptate (input,  1,800, cpm). 
no binding with 16.23 was observed in Rewi lysates (lane f). In 8 M  urea containing 
JuSo lysates heated to 45°C and separated in a urea containing gel, all of the binding 
activity was found in a single band migrating in the position of the/3 subunit (lane 
h). 
Discussion 
The unique allotypic specificity of antibody 16.23 should help to resolve several 
problems that have not yet been clarified in studies using alloantisera or the existing 
monoclonal antibodies. Although two-dimensional electrophoresis (15, 16) and tryptic 
digest peptide mapping  (17,  18)  have demonstrated far more heterogeneity in the 
light (fl) subunit than in the heavy (a) subunit, the actual location of the HLA-DR 
allotypic determinants has remained unclear. Analysis of mouse-human somatic cell 
hybrids  indicated  that  the  allotypic determinants were  associated  with  the  large 
molecular weight (a) subunit (19). In two independent studies, incubation of alloan- 
tisera with isolated subunits resulted in binding exclusively to the a  chains (20) or to 
the,8 chains (21). More recently, immunoprecipitation with alloantisera and absorbed JOHNSON,  MEO,  RIETHMLILLER, SCHENDEL,  AND  WANK  109 
FIo. 3.  Detection of 16.23-binding material in unlabeled cell lysates. Proteins were separated on 
SDS-PAGE (10%, nonreducing conditions), transferred to nitrocellulose filters, and incubated with 
antibody and [12~I]SpA  as described in Materials and Methods. Samples in lanes a and b are 16.23- 
precipitated material from surface iodinated  JuSo B cells heated to 45°C for 30 rain or to 100°C for 
2 min, respectively. Lanes c-h are nitrocellulose filters. Lanes c, d, and e contain JuSo B lysate with 
1% SDS: c, lysate heated to 45°C for 30 min, filter incubated with 16.23; d, lysate heated to 100°C 
for 2 min, filter incubated with 16.23; e, as in d, but filter incubated with rabbit antiserum to DR 
fl chains (1:500). Lanes land g contain Rewi cell (Dw/DR1)  lysate with 1% SDS: f, tysate heated 
to 45°(2 for 30 min, filter incubated with 16.23; g, lysate heated to 100°(2 for 2 min, filter incubated 
with rabbit antiserum  to DR fl chains. Lane h contains JuSo B lysate with 8 M urea, heated to 
45°(2 for 30 min, filter incubated with 16.23. The location of the separated a and fl subunits in the 
urea gel are noted, and BSA (69,000), ovalbumin  (46,000), and trypsinogen (24,000) were used as 
molecular  weight  markers;  the molecular  weights are indicated in kilodaltons  on  the ordinate. 
Molecular weight markers on the SDS gel are as in Fig. 1. 
xenoantisera provided indirect evidence that the DR3 determinant(s) were present on 
the heavy (et) chain (22). Whereas interpretation of these results is complicated by the 
use of polyclonal antisera, discordant observations could be explained by the existence 
of several alloantigen-associated determinants,  some of which  are present  on  the  a 
and  others  on  the  fl  subunits  but  that  are  inherited  together  because  of linkage 
disequilibrium and  are detected to  varying degrees by different  alloantisera. Using 
two independent approaches, antibody 16.23 was shown to bind to the smaller 31,000 
mol  wt  fl  subunit,  clearly  establishing  the  control  of this  subunit  by  HLA  and 
demonstrating that  it carries an epitope of the DR3  phenotype. The relationship of 
the  16.23-bearing  subunit  to  the fl subunits  bearing monomorphic  and  supertypic 
determinants defined by other monoclonal antibodies (3, 6) remains to be investigated. 
Monoclonal  antibodies  directed  against  individual  allotypes  will  be  useful  in 
dissecting the serological cross-reactivities that have been observed between different 
HLA  specificities. In  an  analysis  of more  than  120  individuals  from  the  German 
population,  antibody  16.23  reacted  with  all  HLA-D/DR3  and  with  a  fraction  of 
HLA-Dw/DRw6  individuals (additional typing data from V.  Lenhard, Institute of 
Immunology, University of Heidelberg, Heidelberg, Germany). The lack of reactivity 
with DRw5,  7, and 8 individuals shows that this antibody does not correlate with the 
broad  MB  and  MT  specificities, MB2  or MT2  (23),  and  suggests  that  the  defined 
epitope is shared between  DR3  and at least a  portion of DRw6  cells. Operationally 
monospecific alloantisera for  DRw6  are not  available  (24),  and  assignment  of this 
specificity is presently based on reactivity with three groups of multispecific antisera, 
one  of  which  also  includes  activity  against  HLA-DR3  (25).  An  analysis  of  the 
molecules precipitated by antibody  16.23  from cells of these two phenotypes should 
clarify the relationship between HLA-DR3  and DRw6. 110  MONOCLONAL ANTIBODY AGAINST HLA-DR3 
Finally,  antibody  16.23  is  an  important  tool  for  examining  the  expression  of a 
clearly defined  HLA-DR allospecificity on different cell types, particularly on mac- 
rophages, T  and B lymphocytes, and tumor cells, as well as for studying its functional 
involvement in cellular interactions. 
Summary 
A  murine  monoclonal antibody directed  against  a  human  B  cell  surface  antigen 
with  the  characteristics  of HLA-DR  is  described.  The  antigen  detected  is  tightly 
linked to HLA and is correlated with the alloantigen HLA-Dw/DR3. Reactivity with 
a  fraction of Dw/DRw6  cells  is  also observed.  The determinant  recognized by this 
antibody has been shown to be present on the smaller molecular weight fl subunit of 
the HLA-DR antigen. 
We thank Ingrid Contag and Anne F6rg for expert technical assistance. 
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